Trialect

Verified

NOIP: BRAIN Initiative: Development and Validation of Novel Tools and New Approaches for Neuroscience Research

National Institutes of Health

Note: This is a Forecasted Opportunity.

The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research to develop novel tools and approaches that enable the interrogation of cell-specific and circuit-specific processes in the central nervous system. This NOFO consolidates three current BRAIN Initiative tool development programs.

Projects that focus on developing a broad range of new research tools to delineate anatomical and functional connections between cells and circuits, and to expand our knowledge of brain architecture and function are encouraged, such as projects that:

Develop novel tools to characterize/define cell-types, circuits, and cellular components in the nervous system with greater selectivity and sensitivity, including:
- new genetic or non-genetic technologies/approaches (for delivering genes, proteins, and chemicals to access and/or manipulate cells of interest)
- novel sensors or tracers for imaging or monitoring molecules, structures, and activities within single cells and circuits with significant advances in sensitivity, selectivity, or spatiotemporal resolution
Develop new technologies and novel approaches for recording and modulation of neural cells and circuits, including:
- approaches to address major challenges and enable transformative understanding of dynamic signaling in the central nervous system
- approaches that utilize any modality, such as optical, electrical, magnetic, or acoustic recording/manipulation
- approaches to target neuronal electrical signals or other forms of neural activity, including intracellular signaling and engagement of non-neuronal cells in circuit function.

Projects at broad stages of development are supported, from unique and innovative technologies that are in the earliest stage of development (including new and untested ideas that are in the initial stages of conceptualization) through the optimization of existing instrumentation with transformative potential in order to facilitate broad adoption. Applications that offer transformative approaches that break through existing technical barriers and substantially improve current capabilities are strongly encouraged. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the RP1 activity code.

Estimated Post Date:

Feb 10, 2027

Estimated Application Due Date:

Jun 10, 2027

Specialties

Medical

Medical - Clinical Science

Medical - Basic Science

Medical - Translational

Eligibility Requirements

Sponsor Details

Sponsor Institute/Organizations: National Institutes of Health

Sponsor Type: Government/Federal

Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity